{"id":"https://openalex.org/W7170095083","doi":"https://doi.org/10.1186/s13550-026-01528-3","title":"Targeting EGFR and HER2 in bladder cancer: receptor profiling and therapeutic potential of 213bismuth alpha-particle therapy","display_name":"Targeting EGFR and HER2 in bladder cancer: receptor profiling and therapeutic potential of 213bismuth alpha-particle therapy","publication_year":2026,"publication_date":"2026-10-13","ids":{"openalex":"https://openalex.org/W7170095083","doi":"https://doi.org/10.1186/s13550-026-01528-3"},"language":"en","primary_location":{"id":"doi:10.1186/s13550-026-01528-3","doi":"https://doi.org/10.1186/s13550-026-01528-3","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13550-026-01528-3","pdf_url":null,"source":{"id":"https://openalex.org/S2764570898","display_name":"EJNMMI Research","issn_l":"2191-219X","issn":["2191-219X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EJNMMI Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1186/s13550-026-01528-3","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5121980768","display_name":"Ece Erder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185443292","display_name":"Wayne State University","ror":"https://ror.org/01070mq45","country_code":"US","type":"education","lineage":["https://openalex.org/I185443292"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ece Erder","raw_affiliation_strings":["Translational Neuroscience Program, Wayne State University School of Medicine, Detroit, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Neuroscience Program, Wayne State University School of Medicine, Detroit, MI, USA","institution_ids":["https://openalex.org/I185443292"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028648595","display_name":"Satyendra Kumar Singh","orcid":"https://orcid.org/0000-0001-6795-670X","observed_orcids":["https://orcid.org/0000-0001-6795-670X","https://orcid.org/0000-0002-6937-118X"]},"institutions":[{"id":"https://openalex.org/I87216513","display_name":"Michigan State University","ror":"https://ror.org/05hs6h993","country_code":"US","type":"education","lineage":["https://openalex.org/I87216513"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Satyendra Kumar Singh","raw_affiliation_strings":["College of Veterinary Medicine, Michigan State University, East Lansing, MI, 48824, USA","Departments of Pharmacology & Toxicology, and Radiology, Michigan State University, East Lansing, MI, USA","Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Veterinary Medicine, Michigan State University, East Lansing, MI, 48824, USA","institution_ids":["https://openalex.org/I87216513"]},{"raw_affiliation_string":"Departments of Pharmacology & Toxicology, and Radiology, Michigan State University, East Lansing, MI, USA","institution_ids":["https://openalex.org/I87216513"]},{"raw_affiliation_string":"Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, MI, USA","institution_ids":["https://openalex.org/I87216513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100762730","display_name":"Lu Lucy Xu","orcid":"https://orcid.org/0000-0003-2753-4363","observed_orcids":["https://orcid.org/0000-0003-2753-4363"]},"institutions":[{"id":"https://openalex.org/I87216513","display_name":"Michigan State University","ror":"https://ror.org/05hs6h993","country_code":"US","type":"education","lineage":["https://openalex.org/I87216513"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lu Lucy Xu","raw_affiliation_strings":["Department of Biomedical Engineering, Michigan State University, East Lansing, MI, USA","Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering, Michigan State University, East Lansing, MI, USA","institution_ids":["https://openalex.org/I87216513"]},{"raw_affiliation_string":"Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, MI, USA","institution_ids":["https://openalex.org/I87216513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069017433","display_name":"Chelsea Nayback","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I87216513","display_name":"Michigan State University","ror":"https://ror.org/05hs6h993","country_code":"US","type":"education","lineage":["https://openalex.org/I87216513"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chelsea Nayback","raw_affiliation_strings":["Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, MI, USA","institution_ids":["https://openalex.org/I87216513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000398354","display_name":"Jinda Fan","orcid":"https://orcid.org/0000-0003-3098-3397","observed_orcids":["https://orcid.org/0000-0003-3098-3397"]},"institutions":[{"id":"https://openalex.org/I87216513","display_name":"Michigan State University","ror":"https://ror.org/05hs6h993","country_code":"US","type":"education","lineage":["https://openalex.org/I87216513"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jinda Fan","raw_affiliation_strings":["Department of Chemistry, Michigan State University, East Lansing, MI, USA","Departments of Pharmacology & Toxicology, and Radiology, Michigan State University, East Lansing, MI, USA","Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Michigan State University, East Lansing, MI, USA","institution_ids":["https://openalex.org/I87216513"]},{"raw_affiliation_string":"Departments of Pharmacology & Toxicology, and Radiology, Michigan State University, East Lansing, MI, USA","institution_ids":["https://openalex.org/I87216513"]},{"raw_affiliation_string":"Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, MI, USA","institution_ids":["https://openalex.org/I87216513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111118428","display_name":"Terry Grimm","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I87216513","display_name":"Michigan State University","ror":"https://ror.org/05hs6h993","country_code":"US","type":"education","lineage":["https://openalex.org/I87216513"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Terry Grimm","raw_affiliation_strings":["Department of Small Animal Clinical Sciences, Michigan State University, East Lansing, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Small Animal Clinical Sciences, Michigan State University, East Lansing, MI, USA","institution_ids":["https://openalex.org/I87216513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008809240","display_name":"Daniel Isaac","orcid":"https://orcid.org/0000-0002-8711-649X","observed_orcids":["https://orcid.org/0000-0002-8711-649X"]},"institutions":[{"id":"https://openalex.org/I87216513","display_name":"Michigan State University","ror":"https://ror.org/05hs6h993","country_code":"US","type":"education","lineage":["https://openalex.org/I87216513"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Isaac","raw_affiliation_strings":["Department of Medicine, College of Human Medicine, Michigan State University, East Lansing, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, College of Human Medicine, Michigan State University, East Lansing, MI, USA","institution_ids":["https://openalex.org/I87216513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035876461","display_name":"Mike Zamiara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210125169","display_name":"Niowave (United States)","ror":"https://ror.org/038rwdb10","country_code":"US","type":"company","lineage":["https://openalex.org/I4210125169"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mike Zamiara","raw_affiliation_strings":["Niowave Inc, Lansing, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niowave Inc, Lansing, MI, USA","institution_ids":["https://openalex.org/I4210125169"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040167645","display_name":"Kurt R. Zinn","orcid":"https://orcid.org/0000-0001-7463-4741","observed_orcids":["https://orcid.org/0000-0001-7463-4741"]},"institutions":[{"id":"https://openalex.org/I87216513","display_name":"Michigan State University","ror":"https://ror.org/05hs6h993","country_code":"US","type":"education","lineage":["https://openalex.org/I87216513"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kurt R. Zinn","raw_affiliation_strings":["College of Veterinary Medicine, Michigan State University, East Lansing, MI, 48824, USA","Department of Biomedical Engineering, Michigan State University, East Lansing, MI, USA","Department of Small Animal Clinical Sciences, Michigan State University, East Lansing, MI, USA","Departments of Pharmacology & Toxicology, and Radiology, Michigan State University, East Lansing, MI, USA","Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, MI, USA"],"raw_orcid":"https://orcid.org/0000-0001-7463-4741","affiliations":[{"raw_affiliation_string":"College of Veterinary Medicine, Michigan State University, East Lansing, MI, 48824, USA","institution_ids":["https://openalex.org/I87216513"]},{"raw_affiliation_string":"Department of Biomedical Engineering, Michigan State University, East Lansing, MI, USA","institution_ids":["https://openalex.org/I87216513"]},{"raw_affiliation_string":"Department of Small Animal Clinical Sciences, Michigan State University, East Lansing, MI, USA","institution_ids":["https://openalex.org/I87216513"]},{"raw_affiliation_string":"Departments of Pharmacology & Toxicology, and Radiology, Michigan State University, East Lansing, MI, USA","institution_ids":["https://openalex.org/I87216513"]},{"raw_affiliation_string":"Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, MI, USA","institution_ids":["https://openalex.org/I87216513"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5040167645"],"corresponding_institution_ids":["https://openalex.org/I87216513"],"apc_list":{"value":3190,"currency":"USD","value_usd":3190},"apc_paid":{"value":3190,"currency":"USD","value_usd":3190},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9854000210762024,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9854000210762024,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.011900000274181366,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bladder-cancer","display_name":"bladder cancer","score":0.9599999785423279},{"id":"https://openalex.org/keywords/non-muscle-invasive-bladder-cancer","display_name":"non-muscle-invasive bladder cancer","score":0.9649999737739563},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.9190000295639038},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":1.0},{"id":"https://openalex.org/keywords/targeted-alpha-therapy","display_name":"targeted alpha therapy","score":0.9240000247955322},{"id":"https://openalex.org/keywords/bismuth-213","display_name":"bismuth-213","score":0.9480000138282776},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.8939999938011169},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/antibody-labeling","display_name":"antibody labeling","score":0.37599998712539673},{"id":"https://openalex.org/keywords/dna-damage","display_name":"DNA damage","score":0.781000018119812},{"id":"https://openalex.org/keywords/dna-repair","display_name":"DNA repair","score":0.6460000276565552},{"id":"https://openalex.org/keywords/g2-m-checkpoint","display_name":"G2/M checkpoint","score":0.890999972820282},{"id":"https://openalex.org/keywords/chk1","display_name":"Chk1","score":0.9070000052452087},{"id":"https://openalex.org/keywords/wee1","display_name":"WEE1","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cell-death","display_name":"cell death","score":0.6200000047683716},{"id":"https://openalex.org/keywords/bladder-sparing-therapy","display_name":"bladder-sparing treatment","score":0.5210000276565552}],"concepts":[{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.6866999864578247},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6448000073432922},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.6157000064849854},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.5412999987602234},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.4860999882221222},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4830999970436096},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.45649999380111694},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.4194999933242798},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.41119998693466187},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.41119998693466187},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4007999897003174},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4000000059604645},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.39340001344680786},{"id":"https://openalex.org/C2780306303","wikidata":"https://www.wikidata.org/wiki/Q24784504","display_name":"Folate receptor","level":4,"score":0.37950000166893005},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.3716000020503998},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.3662000000476837},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.33320000767707825},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.3140999972820282},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3125999867916107},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2944999933242798},{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.28619998693466187},{"id":"https://openalex.org/C2778065480","wikidata":"https://www.wikidata.org/wiki/Q2501186","display_name":"Transitional cell carcinoma","level":4,"score":0.26980000734329224},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.26420000195503235},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.2621000111103058},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.260699987411499},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.2587999999523163}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1186/s13550-026-01528-3","doi":"https://doi.org/10.1186/s13550-026-01528-3","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13550-026-01528-3","pdf_url":null,"source":{"id":"https://openalex.org/S2764570898","display_name":"EJNMMI Research","issn_l":"2191-219X","issn":["2191-219X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EJNMMI Research","raw_type":"journal-article"},{"id":"doi:10.21203/rs.3.rs-9886791/v1","doi":"https://doi.org/10.21203/rs.3.rs-9886791/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-9886791/v1","pdf_url":null,"source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1186/s13550-026-01528-3","doi":"https://doi.org/10.1186/s13550-026-01528-3","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13550-026-01528-3","pdf_url":null,"source":{"id":"https://openalex.org/S2764570898","display_name":"EJNMMI Research","issn_l":"2191-219X","issn":["2191-219X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EJNMMI Research","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":38,"referenced_works":["https://openalex.org/W1963694329","https://openalex.org/W1965239527","https://openalex.org/W1972455404","https://openalex.org/W1975655522","https://openalex.org/W1998403654","https://openalex.org/W2000403342","https://openalex.org/W2002045993","https://openalex.org/W2029733869","https://openalex.org/W2037677002","https://openalex.org/W2040860750","https://openalex.org/W2044387885","https://openalex.org/W2096658459","https://openalex.org/W2141454098","https://openalex.org/W2159487877","https://openalex.org/W2169850558","https://openalex.org/W2343997144","https://openalex.org/W2443056117","https://openalex.org/W2573369749","https://openalex.org/W2598217298","https://openalex.org/W2735160137","https://openalex.org/W2768235844","https://openalex.org/W2796474765","https://openalex.org/W2896554027","https://openalex.org/W2911800940","https://openalex.org/W2916183155","https://openalex.org/W2992210399","https://openalex.org/W3042080296","https://openalex.org/W3045644725","https://openalex.org/W3084221577","https://openalex.org/W3092676705","https://openalex.org/W3097629227","https://openalex.org/W3145208530","https://openalex.org/W4292362016","https://openalex.org/W4378347921","https://openalex.org/W4391228304","https://openalex.org/W4398141254","https://openalex.org/W4409134087","https://openalex.org/W4410252493"],"related_works":["https://openalex.org/W7025109498","https://openalex.org/W2262870021","https://openalex.org/W2784133001","https://openalex.org/W3009712809","https://openalex.org/W2254244177","https://openalex.org/W2796474765","https://openalex.org/W2132672867","https://openalex.org/W2116193892","https://openalex.org/W2805962794","https://openalex.org/W2215466275"],"abstract_inverted_index":{"Bladder":[0],"cancer":[1,11,61,77,194],"is":[2],"a":[3],"major":[4],"global":[5],"health":[6],"burden,":[7],"with":[8,22,89,106,157],"non-muscle-invasive":[9],"bladder":[10,60,76,193],"(NMIBC)":[12],"accounting":[13],"for":[14,34,200],"the":[15,32],"majority":[16],"of":[17,29,155,160,168,176],"cases.":[18],"Current":[19],"standard-of-care":[20],"therapy":[21,49,181],"BCG":[23],"fails":[24],"in":[25,58,64,96,145,191],"up":[26],"to":[27,73],"30\u201340%":[28],"patients,":[30],"highlighting":[31],"need":[33],"alternative":[35],"bladder-sparing":[36],"treatments.":[37],"This":[38],"study":[39],"characterized":[40],"EGFR":[41,80],"and":[42,45,67,98,101,126,138,141,149,173],"HER2":[43],"expression":[44,140],"evaluated":[46],"targeted":[47],"alpha-particle":[48],"using":[50,182],"[":[51,90,146],"213":[52,91,110,147,161,177,184],"Bi]":[53],"Bi-labeled":[54,185],"trastuzumab":[55],"plus":[56],"cetuximab":[57,68],"human":[59,75,192],"cell":[62,85,130,195],"lines":[63],"vitro.":[65],"Trastuzumab":[66],"exhibited":[69],"specific,":[70],"high-affinity":[71],"binding":[72],"all":[74],"cells;":[78],"however,":[79],"was":[81],"more":[82],"abundant":[83],"per":[84],"than":[86],"HER2.":[87],"Treatment":[88],"Bi]Bi-trastuzumab+cetuximab":[92,148],"caused":[93],"dose-dependent":[94,114,166],"cytotoxicity":[95],"SCaBER":[97],"RT4":[99],"cells":[100],"increased":[102,107],"DNA-damage":[103],"markers,":[104],"associated":[105],"cell-death":[108],"markers.":[109],"Bi":[111],"treatments":[112],"induced":[113],"transcriptional":[115],"changes":[116],"by":[117],"inducing":[118],"irreparable":[119],"DNA":[120,123],"damage,":[121],"disrupting":[122],"repair":[124],"pathways,":[125],"activating":[127],"multiple":[128],"regulated":[129],"death":[131],"mechanisms.":[132],"Immunoblot":[133],"analysis":[134],"showed":[135],"that":[136],"Chk1":[137],"Wee1":[139],"activation":[142],"were":[143],"comparable":[144],"untreated":[150],"controls":[151],"after":[152],"48":[153],"h":[154],"treatment":[156],"0.3":[158,172],"MBq":[159,175],"Bi.":[162,178],"RNA":[163],"sequencing":[164],"demonstrated":[165,187],"downregulation":[167],"G2M-checkpoint":[169],"markers":[170],"at":[171],"0.56":[174],"Targeted":[179],"alpha":[180],"combined":[183],"trastuzumab+cetuximab":[186],"strong":[188],"preclinical":[189],"efficacy":[190],"lines,":[196],"supporting":[197],"its":[198],"potential":[199],"further":[201],"clinical":[202],"development.":[203]},"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-07-23T00:00:00"}